Developing methods to prevent cancer using genomic data
Official title: Statistical Methods for Precision Prevention
Funded at Fred Hutchinson Cancer Center · NIH-11025722 · Data updated 2026-11-12
This study is exploring new ways to use genetic information to help prevent cancer by understanding what causes it, so that we can better identify who is at risk and create personalized prevention plans, especially by looking closely at tumor characteristics and their surroundings.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | December 4, 2024 |
| Project end | November 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $505,613 |
| NIH project number | 1R01CA297681-01 |
| Project ID | NIH-11025722 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at high risk for developing cancer, particularly those with genetic predispositions or family histories of the disease.
✕Less likely to help
Patients with no genetic risk factors for cancer or those already diagnosed with advanced cancer may not benefit from this research.
What this research studies
This research focuses on creating advanced statistical and computational methods to utilize genomic data for cancer prevention. By analyzing molecular events and understanding the causes of cancer, the project aims to improve risk assessment and develop targeted prevention strategies. The study will leverage cutting-edge technologies, such as spatial omics, to gain insights into tumor characteristics and their environments, which is crucial for distinguishing between aggressive and less harmful tumors. The researchers will address challenges in data analysis to ensure accurate integration of individual risk factors with genomic features.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer prevention strategies tailored to individual risk profiles.
How similar studies have gone: Previous research has shown promise in using genomic data for cancer prevention, indicating that this approach could lead to significant advancements in the field.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Hsu, Li — Fred Hutchinson Cancer Center
- Study coordinator: Hsu, Li
Related research
Other NIH-funded projects on the same topics.
-
How brain glia prune neuron fragments in a worm model
Researchers study how brain support cells called glia remove pieces of living neurons in a tiny worm to learn about brain aging and diseases like Alzheimer's.
-
Understanding and Targeting Lineage Plasticity in Prostate Cancer with Genomic-Based Neoadjuvant Therapy
A broad research program at Fred Hutchinson Cancer Center is exploring how aggressive prostate cancers change their cell states in response to therapy and how to block these changes.
-
Personalized cancer drug testing on patient tumor cells
Aiming to test many FDA-approved cancer drugs on a patient’s own tumor cells to identify effective options when standard therapies fail.
-
MOSAAIC: Using health records to track heart disease in Asian American Communities
A big, dedicated effort is testing whether electronic health records can more quickly and accurately track heart and blood vessel problems in Asian American populations.
-
Targeting gut microbes to prevent progression to multiple myeloma
Researchers are testing how specific gut bacteria might trigger immune changes linked to early blood cancer stages and whether targeting these microbes could help prevent progression to multiple myeloma.
-
eDyNAmiC: Understanding extrachromosomal DNA in cancer and how it drives aggressiveness
A cancer research project at Fred Hutchinson Cancer Center is studying abnormal circular DNA pieces (ecDNA) that help cancers grow and resist treatment, with the aim of finding ways to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.